Reports related to this article:
Project(s): View 3 related projects in PECWeb
Plant(s): View 3 related plants in PECWeb
Released July 01, 2024 | CORDOBA, ARGENTINA
en
Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info continues to monitor investments related to the growing use of renewable energy within Latin America's pharmaceutical and biotechnology industry.
The installation of photovoltaic panels is the most notable aspect of this growth trend, showing that pharmaceutical plants are betting on renewable power.
Most companies that install grassroot plants already do so with the concept of using renewable energy. Firms that have not yet decided to venture into this trend--often due to the costs and/or the lack of physical availability to do it--enter into contracts with third parties for green energy. So far, renewable energy has demonstrated it is a sustainable solution that facilitates production levels that are economically viable and above all constant.
Industrial Info is monitoring more than US$118 million in projects that specifically involve photovoltaic panels within the pharmaceutical industry in the region. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of detailed project reports.
Investments by companies such as Novo Nordisk (NYSE:NVO) (Bagsværd, Denmark) (more than US$40 million in Montes Claros, Brazil); Boehringer Ingelheim (Ingelheim am Rhein, Germany) (US$5 million in Paulinia, Brazil); and Medtronic plc (NYSE:MDT) (Minneapolis, Minnesota) (US$2.5 million in Tijuana, Mexico), stand out.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 Trillion (USD).
The installation of photovoltaic panels is the most notable aspect of this growth trend, showing that pharmaceutical plants are betting on renewable power.
Most companies that install grassroot plants already do so with the concept of using renewable energy. Firms that have not yet decided to venture into this trend--often due to the costs and/or the lack of physical availability to do it--enter into contracts with third parties for green energy. So far, renewable energy has demonstrated it is a sustainable solution that facilitates production levels that are economically viable and above all constant.
Industrial Info is monitoring more than US$118 million in projects that specifically involve photovoltaic panels within the pharmaceutical industry in the region. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of detailed project reports.
Investments by companies such as Novo Nordisk (NYSE:NVO) (Bagsværd, Denmark) (more than US$40 million in Montes Claros, Brazil); Boehringer Ingelheim (Ingelheim am Rhein, Germany) (US$5 million in Paulinia, Brazil); and Medtronic plc (NYSE:MDT) (Minneapolis, Minnesota) (US$2.5 million in Tijuana, Mexico), stand out.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking more than 200,000 current and future projects worth $17.8 Trillion (USD).
